INSILICO(03696.HK) closed 10.1% higher
NewTimeSpace News: By the close of trading on Apr 22, 2026, INSILICO(03696.HK) saw a gain of 10.1% in its share price, closing at HKD 75.25. During the session, it reached an intraday high of HKD 75.9 and touched an intraday low of HKD 67.15. The full-day turnover stood at HKD 553.67 million, with significant volume growth, with the latest market capitalization at HKD 43.07 billion.
On the sector front, the Hang Seng Pharmaceuticals & Biotechnology Sector, to which INSILICO belongs, showed an overall divergence trend, with 48 stocks advancing and 93 stocks declining.Among the gainers, CLOUDBREAK-B closed higher by 16.43%, INSILICO closed higher by 10.1%, NT PHARMA closed higher by 9.23%, JW THERAP-B closed higher by 7.11%, HAIXI PHARMA closed higher by 6.63%.Among the decliners, XUANZHUBIO-B closed lower by 10.23%, AIM VACCINE closed lower by 10.19%, 160 HEALTH closed lower by 9.65%, PEGBIO CO-B closed lower by 9.44%, XTALPI closed lower by 6.32%.
NewTimeSpace Disclaimer:All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- INSILICO (03696.HK) signs AI drug R&D pact with Luoxin Pharmaceutical
- INSILICO (03696.HK): First-in-Human ISM6331 Data Show 40% ORR in 130mg Mesothelioma Cohort
- ILUVATAR COREX (09903.HK): banking facilities over RMB12 billion granted, over 80% unutilized, supporting business expansion
- INSILICO (03696.HK): Servier AI drug discovery milestone hit
- INSILICO (03696.HK): Nominates ISM9546 as 35th Preclinical Candidate